脑部放疗,上午比下午敏感许多!9 G; p% z+ |% J% a
5 K+ q. H; f5 c/ A0 w( X
8 o @1 ~8 k b! n: P. d c2 U6 V
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.# N2 m! }% M) K( Y( Q5 ^( L
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, @/ v0 t4 Q# A' o% ORahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
# B. X( ~% l) v f7 K- c9 _2 USourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
* g4 a3 z2 s8 D
2 ]6 {; Q- t7 h- q9 d& QAbstract
4 Q8 m1 `: R1 A" s. x- Z0 U+ RBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.! b: Y. n' L1 K o' z0 i+ X
$ E8 `. P) U) o+ c" e- ^+ Z
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
/ Z+ l: @# G6 \1 O' ~
$ c3 p5 d+ u( u- q& LRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)., q2 m" i" x* h: T
' N( Q3 V3 C& bCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
) Y( r$ T: _9 v; |. `3 m1 u8 S, u# f0 [; q! ~: K0 g' ?$ L3 R
|